1-4 of 4
Tony Jiang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Fixed-duration epcoritamab monotherapy induces high response and MRD-negativity rates in elderly patients with newly diagnosed large B-cell lymphoma (LBCL) and comorbidities: Results from EPCORE DLBCL-3

Free
Umberto Vitolo, Johannes Duell, Juan Miguel Bergua Burgues, Wojciech Jurczak, Michal Kwiatek, Marie Maerevoet, Sergio Ortegon Alcaide, David Belada, Won Seog Kim, Richard Greil, Raul Cordoba, Juan-Manuel Sancho, David Sibon, Catherine Thieblemont, Takahiro Kumode, Monica Wielgos-Bonvallet, Tony Jiang, Yanli Wang, Stephanie McGoldrick, Evelyn Guo, Franck Morschhauser, Sherida Woei-A-Jin
Journal: Blood
Blood (2025) 146 (Supplement 1): 63.
https://doi.org/10.1182/blood-2025-63
Published: 2025
Journal Articles

Epcoritamab + GemOx achieves durable >2-year remissions in relapsed/refractory (R/R) 2L+ diffuse large B-cell lymphoma (DLBCL): Long-term data reinforce clinical potential of the regimen across a diverse patient population

Free
Joshua Brody, David Belada, Daniel Morillo, Régis Costello, Marek Trneny, Sven de Vos, Gerardo Musuraca, Umberto Vitolo, David Lewis, Jacob Christensen, Marcel Nijland, Tony Jiang, Kubra Karagoz, Andrew J. Steele, Jennifer Marek, Liwei Wang, Malene Risum, Raul Cordoba, Judit Jørgensen
Journal: Blood
Blood (2025) 146 (Supplement 1): 3736.
https://doi.org/10.1182/blood-2025-3736
Published: 2025
Journal Articles

Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial

Open Access
Clinical Trials & Observations
Joshua D. Brody, Judit Jørgensen, David Belada, Régis Costello, Marek Trněný, Umberto Vitolo, David John Lewis, Yasmin H. Karimi, Anna Sureda, Marc André, Björn E. Wahlin, Pieternella J. Lugtenburg, Tony Jiang, Kubra Karagoz, Andrew J. Steele, Aqeel Abbas, Liwei Wang, Malene Risum, Raul Cordoba
Journal: Blood
Blood (2025) 145 (15): 1621–1631.
https://doi.org/10.1182/blood.2024026830
Published: 2025
Includes: Supplemental data
Journal Articles

A Phase 1/2, First-in-Human, Multicenter, Open-Label, Dose Escalation and Dose-Expansion Study of Single-Agent ISB 1442 in Patients with Relapsed/Refractory Multiple Myeloma

Free
Hanlon Sia, Peter T. Tan, Joshua Richter, Phoebe Joy Ho, Tara Cochrane, Hang Quach, Binod Dhakal, Igor Proscurshim, Tony Jiang, Emaryn Mancino, Yacine Salhi, Sammicheli Stefano, Girish Gudi, Andrew Garton, Eric J. Feldman, Andrew Spencer
Journal: Blood
Blood (2022) 140 (Supplement 1): 10182–10184.
https://doi.org/10.1182/blood-2022-157585
Published: 2022